| International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors—an update BB Fredholm, AP IJzerman, KA Jacobson, J Linden, CE Müller Pharmacological reviews 63 (1), 1-34, 2011 | 1640 | 2011 |
| Recent developments in adenosine receptor ligands and their potential as novel drugs CE Müller, KA Jacobson Biochimica et Biophysica Acta (BBA)-Biomembranes 1808 (5), 1290-1308, 2011 | 522 | 2011 |
| The Concise Guide to PHARMACOLOGY 2021/22: G protein‐coupled receptors SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ... British journal of pharmacology 178, S27-S156, 2021 | 503 | 2021 |
| Anthraquinones as pharmacological tools and drugs EM Malik, CE Müller Medicinal research reviews 36 (4), 705-748, 2016 | 487 | 2016 |
| Structure of the human P2Y12 receptor in complex with an antithrombotic drug K Zhang, J Zhang, ZG Gao, D Zhang, L Zhu, GW Han, SM Moss, ... Nature 509 (7498), 115-118, 2014 | 468 | 2014 |
| Adenosine activates brown adipose tissue and recruits beige adipocytes via A2A receptors T Gnad, S Scheibler, I von Kügelgen, C Scheele, A Kilić, A Glöde, ... Nature 516 (7531), 395-399, 2014 | 417 | 2014 |
| The experimental power of FR900359 to study Gq-regulated biological processes R Schrage, AL Schmitz, E Gaffal, S Annala, S Kehraus, D Wenzel, ... Nature communications 6 (1), 10156, 2015 | 381 | 2015 |
| Agonist-bound structure of the human P2Y12 receptor J Zhang, K Zhang, ZG Gao, S Paoletta, D Zhang, GW Han, T Li, L Ma, ... Nature 509 (7498), 119-122, 2014 | 378 | 2014 |
| Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress MP Kaster, NJ Machado, HB Silva, A Nunes, AP Ardais, M Santana, ... Proceedings of the National Academy of Sciences 112 (25), 7833-7838, 2015 | 336 | 2015 |
| Striatal adenosine A2A and cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids P Carriba, O Ortiz, K Patkar, Z Justinova, J Stroik, A Themann, C Müller, ... Neuropsychopharmacology 32 (11), 2249-2259, 2007 | 328 | 2007 |
| CD39/ENTPD1 expression by CD4+ Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice X Sun, Y Wu, W Gao, K Enjyoji, E Csizmadia, CE Müller, T Murakami, ... Gastroenterology 139 (3), 1030-1040, 2010 | 309 | 2010 |
| Medicinal chemistry of adenosine, P2Y and P2X receptors KA Jacobson, CE Müller Neuropharmacology 104, 31-49, 2016 | 298 | 2016 |
| Update of P2X receptor properties and their pharmacology: IUPHAR Review 30 P Illes, CE Müller, KA Jacobson, T Grutter, A Nicke, SJ Fountain, ... British Journal of Pharmacology 178 (3), 489-514, 2021 | 272 | 2021 |
| Prodrug approaches for enhancing the bioavailability of drugs with low solubility CE Müller Chemistry & Biodiversity 6 (11), 2071-2083, 2009 | 265 | 2009 |
| Lignans Isolated from Valerian: Identification and Characterization of a New Olivil Derivative with Partial Agonistic Activity at A1 Adenosine Receptors B Schumacher, S Scholle, J Hölzl, N Khudeir, S Hess, CE Müller Journal of Natural Products 65 (10), 1479-1485, 2002 | 257 | 2002 |
| Crystal structure of the human ecto-5′-nucleotidase (CD73): insights into the regulation of purinergic signaling K Knapp, M Zebisch, J Pippel, A El-Tayeb, CE Müller, N Sträter Structure 20 (12), 2161-2173, 2012 | 241 | 2012 |
| Structure–activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP) A Pick, H Müller, R Mayer, B Haenisch, IK Pajeva, M Weigt, H Bönisch, ... Bioorganic & medicinal chemistry 19 (6), 2090-2102, 2011 | 240 | 2011 |
| Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration M Karcz-Kubicha, K Antoniou, A Terasmaa, D Quarta, M Solinas, ... Neuropsychopharmacology 28 (7), 1281-1291, 2003 | 232 | 2003 |
| Dopaminergic modulation of effort-related choice behavior as assessed by a progressive ratio chow feeding choice task: pharmacological studies and the role of individual … PA Randall, M Pardo, EJ Nunes, L López Cruz, VK Vemuri, A Makriyannis, ... Public Library of Science 7 (10), e47934, 2012 | 224 | 2012 |
| Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease MT Armentero, A Pinna, S Ferré, JL Lanciego, CE Müller, R Franco Pharmacology & therapeutics 132 (3), 280-299, 2011 | 224 | 2011 |
Younis BaqiSultan Qaboos UniversityVerified email at squ.edu.om